Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry.


Journal

Thrombosis research
ISSN: 1879-2472
Titre abrégé: Thromb Res
Pays: United States
ID NLM: 0326377

Informations de publication

Date de publication:
May 2019
Historique:
received: 15 01 2019
revised: 18 02 2019
accepted: 23 02 2019
pubmed: 3 3 2019
medline: 7 1 2020
entrez: 3 3 2019
Statut: ppublish

Résumé

There is a paucity of data on patients with deep vein thrombosis (DVT) in upper extremities. The COMMAND VTE Registry is a retrospective multicenter registry enrolling 3027 consecutive patients with acute symptomatic venous thromboembolism (VTE) in Japan. The current study population included 2498 patients with upper or lower extremities DVT. There were 74 patients (3.0%) with upper extremities DVT and 2424 patients with lower extremities DVT. Patients with upper extremities DVT more often had active cancer (58%) and central venous catheter use (22%). The proportion of concomitant pulmonary embolism at diagnosis was lower in patients with upper extremities DVT than in those with lower extremities DVT (14% and 51%, P < 0.001). Discontinuation of anticoagulation therapy was more frequent in patients with upper extremities DVT (63.8% and 29.8% at 1-year, P < 0.001). The cumulative 3-year incidence of recurrent VTE was not different between the 2 groups (9.8% and 7.4%, P = 0.43). After adjusting confounders, the risks of upper extremities DVT relative to lower extremities DVT for recurrent VTE remained insignificant (HR 0.94, 95%CI 0.36-2.01, P = 0.89). The prevalence of patients with DVT in upper extremities was 3.0% in the current large-scale real-world registry. Patients with DVT in upper extremities more often had active cancer at diagnosis and central venous catheter use as a transient risk factor for VTE, and less often had concomitant PE. Patients with DVT in upper extremities had similar long-term risk for recurrent VTE as those with DVT in lower extremities despite shorter duration of anticoagulation.

Identifiants

pubmed: 30825719
pii: S0049-3848(19)30074-X
doi: 10.1016/j.thromres.2019.02.029
pii:
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-9

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Yugo Yamashita (Y)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Takeshi Morimoto (T)

Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan.

Hidewo Amano (H)

Department of Cardiovascular Medicine, Kurashiki Central Hospital, Kurashiki, Japan.

Toru Takase (T)

Department of Cardiology, Kinki University Hospital, Osaka, Japan.

Seiichi Hiramori (S)

Department of Cardiology, Kokura Memorial Hospital, Kokura, Japan.

Kitae Kim (K)

Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.

Maki Oi (M)

Department of Cardiology, Japanese Red Cross Otsu Hospital, Otsu, Japan.

Masaharu Akao (M)

Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Yohei Kobayashi (Y)

Department of Cardiovascular Center, Osaka Red Cross Hospital, Osaka, Japan.

Mamoru Toyofuku (M)

Department of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.

Toshiaki Izumi (T)

Cardiovascular Center, The Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan.

Tomohisa Tada (T)

Department of Cardiology, Shizuoka General Hospital, Shizuoka, Japan.

Po-Min Chen (PM)

Department of Cardiology, Osaka Saiseikai Noe Hospital, Osaka, Japan.

Koichiro Murata (K)

Department of Cardiology, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.

Yoshiaki Tsuyuki (Y)

Division of Cardiology, Shimada Municipal Hospital, Shimada, Japan.

Syunsuke Saga (S)

Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.

Yuji Nishimoto (Y)

Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.

Tomoki Sasa (T)

Department of Cardiology, Kishiwada City Hospital, Kishiwada, Japan.

Jiro Sakamoto (J)

Department of Cardiology, Tenri Hospital, Tenri, Japan.

Minako Kinoshita (M)

Department of Cardiology, Nishikobe Medical Center, Kobe, Japan.

Kiyonori Togi (K)

Division of Cardiology, Nara Hospital, Kinki University Faculty of Medicine, Ikoma, Japan.

Hiroshi Mabuchi (H)

Department of Cardiology, Koto Memorial Hospital, Higashiomi, Japan.

Kensuke Takabayashi (K)

Department of Cardiology, Hirakata Kohsai Hospital, Hirakata, Japan.

Yusuke Yoshikawa (Y)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Hiroki Shiomi (H)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Takao Kato (T)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Takeru Makiyama (T)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Koh Ono (K)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Takeshi Kimura (T)

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: taketaka@kuhp.kyoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH